Medifast, Inc. (FRA:MDF)

Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of EUR 94.95 million. The enterprise value is -43.76 million.

Market Cap	94.95M
Enterprise Value	-43.76M

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	10.28M
Shares Outstanding	n/a
Shares Change (YoY)	+0.27%
Shares Change (QoQ)	-0.62%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	84.20%
Float	9.17M

Valuation Ratios

The trailing PE ratio is 449.20.

PE Ratio	449.20
Forward PE	n/a
PS Ratio	0.26
PB Ratio	0.52
P/TBV Ratio	0.52
P/FCF Ratio	172.45
P/OCF Ratio	15.49
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-207.04
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-79.48

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.06.

Current Ratio	4.45
Quick Ratio	3.71
Debt / Equity	0.06
Debt / EBITDA	0.48
Debt / FCF	18.98
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.12% and return on invested capital (ROIC) is 1.88%.

Return on Equity (ROE)	0.12%
Return on Assets (ROA)	1.52%
Return on Invested Capital (ROIC)	1.88%
Return on Capital Employed (ROCE)	3.07%
Revenue Per Employee	726,645
Profits Per Employee	419
Employee Count	504
Asset Turnover	1.54
Inventory Turnover	3.74

Taxes

In the past 12 months, Medifast has paid 1.51 million in taxes.

Income Tax	1.51M
Effective Tax Rate	87.71%

Stock Price Statistics

The stock price has decreased by -50.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-50.86%
50-Day Moving Average	10.13
200-Day Moving Average	11.17
Relative Strength Index (RSI)	31.86
Average Volume (20 Days)	5

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	12.56

Income Statement

In the last 12 months, Medifast had revenue of EUR 366.23 million and earned 211,370 in profits. Earnings per share was 0.02.

Revenue	366.23M
Gross Profit	265.29M
Operating Income	5.80M
Pretax Income	1.72M
Net Income	211,370
EBITDA	17.70M
EBIT	5.80M
Earnings Per Share (EPS)	0.02

Balance Sheet

The company has 147.88 million in cash and 10.45 million in debt, giving a net cash position of 137.43 million.

Cash & Cash Equivalents	147.88M
Total Debt	10.45M
Net Cash	137.43M
Net Cash Per Share	n/a
Equity (Book Value)	182.99M
Book Value Per Share	17.81
Working Capital	137.33M

Cash Flow

In the last 12 months, operating cash flow was 6.13 million and capital expenditures -5.58 million, giving a free cash flow of 550,586.

Operating Cash Flow	6.13M
Capital Expenditures	-5.58M
Free Cash Flow	550,586
FCF Per Share	n/a

Margins

Gross margin is 72.44%, with operating and profit margins of 1.58% and 0.06%.

Gross Margin	72.44%
Operating Margin	1.58%
Pretax Margin	0.47%
Profit Margin	0.06%
EBITDA Margin	4.83%
EBIT Margin	1.58%
FCF Margin	0.15%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	78.63%
Buyback Yield	-0.27%
Shareholder Yield	-0.27%
Earnings Yield	0.22%
FCF Yield	0.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 5.12 and a Piotroski F-Score of 5.

Altman Z-Score	5.12
Piotroski F-Score	5